Close
What would you like to look for?
Site search
21 October 2022

Norgine Ventures has provided financing of approx. EUR 10 million to Lunaphore Technologies.The financing was realised in form of private bonds with warrants which can be drawn down in multiple tranches. Lunaphore Technologies S.A., in Lausanne, has developed a game-changing chip technology which can extract spatial proteomic and genomic data from tumors and transform any simple assay into multiplex spatial biology without complexity. Norgine Ventures is a business entity of Norgine, an independent pan-European specialty pharmaceutical comp. VISCHER is advising Norgine Ventures with Matthias Staehelin (Partner, Corporate/M&A), Adrian Dörig (Partner, Corporate/M&A) and Christian Schneiter (Senior Associate, Corporate/M&A).

Authors